---
schema_version: "secwatch.filing_event.v1"
accession: "0001447362-22-000203"
form_type: "8-K"
ticker: "CSTL"
cik: "0001447362"
company_name: "CASTLE BIOSCIENCES INC"
filed_at: "2022-12-28T23:59:59+00:00"
generated_at: "2026-06-20T22:23:43.350498+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Castle Biosciences adopts 2022 Inducement Plan for 350,000 shares to attract new employees

## Summary
- Board approved 2022 Inducement Plan reserving 350,000 shares of common stock for new hires as material inducement.
- Plan adopted without stockholder approval under Nasdaq Listing Rule 5635(c)(4).
- Awards include nonstatutory stock options, SARs, restricted stock, RSUs, and performance-based awards.
- Terms substantially similar to the company's stockholder-approved 2019 Equity Incentive Plan.

## SEC filing metadata
- accession: 0001447362-22-000203
- form_type: 8-K
- ticker: CSTL
- cik: 0001447362
- company_name: CASTLE BIOSCIENCES INC
- filed_at: 2022-12-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1447362/000144736222000203/0001447362-22-000203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1447362/000144736222000203/cstl-20221222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001447362-22-000203
- JSON: https://secwatch.observer/filing/0001447362-22-000203.json
- Plain text: https://secwatch.observer/filing/0001447362-22-000203.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.